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Abstract
Background: Jumping alignments have recently been proposed as a strategy to search a given
multiple sequence alignment A against a database. Instead of comparing a database sequence S to
the multiple alignment or profile as a whole, S is compared and aligned to individual sequences from
A. Within this alignment, S can jump between different sequences from A, so different parts of S can
be aligned to different sequences from the input multiple alignment. This approach is particularly
useful for dealing with recombination events.
Results:  We developed a jumping profile Hidden Markov Model (jpHMM), a probabilistic
generalization of the jumping-alignment approach. Given a partition of the aligned input sequence
family into known sequence subtypes, our model can jump between states corresponding to these
different subtypes, depending on which subtype is locally most similar to a database sequence.
Jumps between different subtypes are indicative of intersubtype recombinations. We applied our
method to a large set of genome sequences from human immunodeficiency virus (HIV) and hepatitis
C virus (HCV) as well as to simulated recombined genome sequences.
Conclusion: Our results demonstrate that jumps in our jumping profile HMM often correspond
to recombination breakpoints; our approach can therefore be used to detect recombinations in
genomic sequences. The recombination breakpoints identified by jpHMM were found to be
significantly more accurate than breakpoints defined by traditional methods based on comparing
single representative sequences.
Background
Profile Hidden Markov Models [1] are a popular way of
modelling nucleic-acid or protein sequence families for
database searching, see [2] for a review. Like other Hidden
Markov Models (HMMs), profile HMMs consist of so-
called states that can emit symbols of the underlying alpha-
bet, i.e. nucleotides or amino acids [3]. Transitions are pos-
sible between these states, and a DNA or protein sequence
is thought to be generated by a path Q through the model
beginning with a special begin state and ending with an
end state. There are probabilities (a) for possible transi-
tions from one state to another and (b) for the emission of
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symbols at a given state. The states together with the pos-
sible transitions between them are called the topology of
the model while the corresponding transition and emis-
sion probabilities are called its parameters. A sequence S is
generated by the model with a certain probability P(S). In
general, a sequence S can be generated by more than one
path Q through the model. For a given sequence S, the
well-known Viterbi Algorithm [4] finds the most probable
path that generates S. More precisely, the algorithm finds
a path Q* that maximizes the conditional probability
P(Q|S) which is equivalent to maximizing the joint prob-
ability P(Q, S). For a general introduction to HMMs, see
[5].
The starting point for a profile HMM is a multiple align-
ment of a sequence family. Columns of the alignment are
modeled as states of the HMM. These states are called
match states and are denoted by Mi; the indexing is such
that the alignment column associated with a match state
Mi is to the left of the column associated with Mj whenever
i < j. Emission probabilities for a match state Mi depend
on nucleotide or amino acid frequencies in the respective
alignment column. In general, not every column of the
input multiple alignment corresponds to a match state,
but only those columns that have a certain minimum
number of non-gap characters are modeled as match
states. Columns that correspond to match states are called
consensus columns. State transitions are possible from one
match state Mi to the next match state Mi+1. To account for
insertions and deletions, additional states are defined.
Insert states Ii can emit additional symbols while delete
states Di can be used to omit one or more match states in
the model. As the Begin and End states, delete states are
silent, i.e. they do not emit any symbols. Figure 1 shows
the topology of a profile HMM. An insert state Ii is located
between the match states Mi and Mi+1 and there are possi-
ble transitions from Mi to Ii and from Ii to Mi+1 such that
an additional character can be inserted between Mi and
Mi+1. By contrast, a deletion state Di is in the same column
as a match state Mi. There are possible transitions from Mi-
1 to Di and from Di to Mi+1 to circumvent match state Mi.
Profile HMMs are frequently used tools for database
searching. They are slower but more accurate than stand-
ard local-alignment approaches such as BLAST [6]. The
best known implementation of profile HMMs is Sean
Eddy's software program HMMer [2,7].
Jumping alignments have been proposed by Spang et al. as
a new approach to database searching [8,9]. Like profile
HMMs, jumping alignments start with a multiple alignment
A of a sequence family, and database sequences S are com-
pared to A. But unlike in standard methods, the database
sequence is not aligned to the query multiple alignment A
or to the corresponding profile as a whole, but the pro-
gram aligns segments from the database sequence S to sin-
gle  sequences from the multiple alignment A. Each
position of S is aligned with only one sequence from A,
the so-called reference sequence for this position. Within
one alignment, the program can jump between the refer-
ence sequences. For such jumps a penalty is imposed sim-
ilar to the gap penalties that are used in standard
alignment algorithms.
In the present paper, we describe a novel approach to
compare a single nucleic acid or protein sequence to a
multiple alignment of a sequence family. Our approach
combines the above outlined methods and can be seen as
a probabilistic generalization of the jumping-alignment
approach. We therefore call our method jumping profile
Hidden Markov Model (jpHMM). The proposed tool is a
A profile hidden Markov model as introduced by Krogh et al Figure 1
A profile hidden Markov model as introduced by Krogh et al. [1]. Squares indicate match states (Mi), diamonds insert states (Ii) 
and circles delete states (Di). Possible transitions are shown as arrows. Begin state (B), End state (E) and delete states (Di) are 
silent states, i.e. they do not emit symbols of the alphabet.
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flexible method for database searching; it is particularly
useful if sequence recombinations have to be taken into
account. In the present study, we apply our method to
localize phylogenetic breakpoints in viral genome
sequences. We applied our approach to identify genomic
recombinations in HIV and HCV and to classify subtypes.
Accurate classification of HIV and HCV sequences is of
crucial importance for epi-demiological monitoring as
well as for the design of molecular detection systems and
potential vaccines. HIV and HCV are among the most
genetically variable organisms known. Based on phyloge-
netic clustering, these viruses have been classified into
clades (Figure 2). The classification is not always trivial,
because genetic forms that do not cluster within the phyl-
ogenetic clusters exist, and for both viruses recombinants
have been discovered that make the classification more
obscure. Furthermore, some genes and genome segments
do not contain enough information to resolve the sub-
types, especially when DNA sequences become too short.
Most classification methods depend on an accurate
sequence alignment, and those that do not, still depend
on pair-wise comparisons between a query sequence and
some set of reference sequences. Since the subtypes are
phylogenetically defined, tree building is the gold stand-
ard. Reconstructing accurate phylogenetic trees is, how-
ever, neither trivial nor easy to incorporate in automatic
screening procedures. In recent years, many methods have
been developed to detect genomic recombinations based
on phylogenetic trees, sequence patterns and population
Complete genome trees of the hepatitis C and HIV-1 (M group) viruses Figure 2
Complete genome trees of the hepatitis C and HIV-1 (M group) viruses. The trees are drawn on the same scale. Only non-
recombinant complete genomes have been included. The trees are based on manually curated alignments containing only one 
sequence per patient. The optimalization method was maximum-likelihood, as implemented in the GAML/Garli program 
(Zwickl et al. 2005, in preparation).BMC Bioinformatics 2006, 7:265 http://www.biomedcentral.com/1471-2105/7/265
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genetics. In the virology field, the most popular methods
have been based on pair-wise genetic distance calcula-
tions. Generally, HIV recombination is detected based on
pairwise distances [10] and breakpoint locations are
defined based on a method called "informative sites anal-
ysis" [11,12] prior to generating phylogenies, which are
then used to validate the level of support for recombina-
tion in different genomic regions. Alternatively a bootscan
is performed to determine whether phylogenetic branch-
ing patterns differ in trees constructed based on a sliding
window approach [13]. Informative sites analysis divides
the sequence at the midpoint between the substitutions
that mark the dividing point that gives the most support
for the recombination events using a chi square test; single
representatives of the two recombinant clades are com-
pared to the query sequence. In contrast, the jpHMM
approach that we propose in this paper enables defining
breakpoints based on a model derived from the full align-
ment of a particular clade; this is particularly useful when
the precise parental strain is not known, rather a parental
lineage is defined.
HIV-1 is classified into three major phylogenetic groups,
called M, N and O, that arose due to separate introduc-
tions of SIVs from chimpanzees into humans [14]. The M
group, which is responsible for the HIV pandemic, is fur-
ther divided into ten subtypes, some of which have been
even further subdivided into sub-subtypes [15]. Inter-sub-
type recombination is extremely common among HIV-1
subtypes [16]. Identifying intersubtype recombinants is
important from many perspectives, giving insights into
such issues as molecular epidemiology, viral evolution,
and indirectly, the frequency of dual infections.
For hepatitis C, the picture is even more complex; there
are currently 6 major genotypes, each subdivided into
subtypes, of which there can be dozens. To curb the explo-
sion in new subtypes, it was recently decided that new
subtypes will only be named when there are at least three
unrelated samples for them [17]. Recombinants that have
been epidemiologically successful exist for both viruses,
and are called CRFs in HIV and RFs in HCV, for (circulat-
ing) recombinant forms. HIV CRFs are common, and they
often emerge as the dominant clade in a regional epi-
demic [18]. More precise breakpoint definitions will help
in identifying and tracking HIV CRFs.
Currently only a small number of naturally occurring
recombinants have been identified for the hepatitis C
virus, despite frequent dual infection [19,20,20-24]. Until
2005, only one circulating recombinant form had been
described, from St. Petersburg [25]. However, the discov-
ery of new recombinants does appear to be speeding up,
with two recent publications describing new circulating
recombinants between genotypes 2a and 2c from Peru
[26], and between genotypes 2i and 6h from Vietnam (S.
Noppornpanth, unpublished results). It is very likely that
more recombinants will be discovered in the near future.
Discovery and accurate characterization of new recom-
binants is hampered by the scarcity of complete genome
sequences for most of the less frequent HCV genotypes.
Recombinants found for hepatitis C so far are simple in
structure, none of them appear to combine fragments
from more than two genotypes and all appear to contain
only one breakpoint. Thus, characterizing HCV recom-
binants found to date is a simpler task than characterizing
the complex recombinants that are often found in HIV
(for review, see [15]), for a specific example of the com-
plexity, see [27]. However, given the improved sampling
and sequencing capacity in HCV and the associated grow-
ing frequency of detection of recombinants, it will be
increasingly important to have a tool that can reliably and
efficiently identify recombinants and locate their break-
points.
Results
Jumping profile Hidden Markov Model
A jumping profile Hidden Markov Model (jpHMM) as
introduced in this section combines profile HMMs with
the jumping alignment (JALI) approach introduced by
Spang et al. [9]. The data that a jpHMM models are a
sequence family  = {S1,...,Sn} together with a multiple
sequence alignment A of  . In addition, we assume that
we have a partition of   into k subtypes  1,..., k such
that each sequence Si belongs to exactly one of the sub-
types. Our jpHMM approach can be seen as a generaliza-
tion of the 'jumping alignment' algorithm. In JALI, each
position of a database sequence is aligned to one reference
sequence Si ∈  . By contrast, jpHMM aligns parts of the
input sequence to entire subtypes of the input multiple
alignment. Thus, JALI corresponds to the special case in
our approach where each subtype  i consists of exactly
one sequence. As with standard profile HMMs, each
match state in our model is derived from one column of
the input alignment A. However, in our model we define
match states specific for the subtypes. Thus, a column in
the query alignment A may correspond to up to k match
states, and a match state is specified by two indices, the
corresponding column of the multiple alignment A and
the subtype it belongs to.
For a given subtype  i, a column is modeled as a match
state only if it is a consensus column for that subtype.
Consequently, a column i  in the alignment A  may be

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modeled as a match state for some of the subtypes but not
for other subtypes. In addition to the match states, we
have distinct insert and delete states for each subtype just
as in standard profile HMMs. In our notation, match state
Mi,j is the j-th match state within the i-th subtype, and Ii,j
and Di,j are the insert and delete states corresponding to
Mi,j. There is a single Begin state and a single End state,
respectively, for the entire model. Further, there are gen-
eral, not subtype-specific insert and delete states just after
the Begin state and just before the End state. From the
delete state immediately after the Begin state, each match
state from each subtype can be reached. Similarly, from
each match state, the delete state directly before the End
state can be reached. These states have been introduced to
deal with the fact that the sequences are often incom-
pletely sequenced and are missing the initial or terminal
part.
Note that the sub-model associated with a subtype  i in
our jpHMM corresponds to a standard profile HMM for
i. Thus, our model can be seen as the union of k stand-
ard profile HMMs with additional transitions between
these standard HMMs. The underlying multiple align-
ment A induces a quasi partial order relation on the set of all
states of our jpHMM. We say that a match or delete state
T is (strictly) to the left of a match or delete state R if the
alignment column associated to T is (strictly) to the left of
the column associated with R. This ordering is related to
the quasi partial order relation A defined on the set of all
sites of a multiple alignment introduced in [28] in the con-
text of consistency of alignments. As for standard HMMs,
the states of a jpHMM are connected by transitions to
which transition probabilities are assigned. Transitions
are possible within one subtype  i as in standard profile
HMMs, e.g. from one match state a transition is possible
to the next match state or to the corresponding insert and
delete states of  i. In addition, our model allows transi-
tions between different subtypes as shown in Figures 3 and
4. Transitions between subtypes are called jumps.
Transitions between subtypes are more complicated than
within subtypes since not every alignment column is rep-
resented in every subtype as a match state. Thus, it is not
obvious from which state in one subtype we can jump to
which state in another subtype, so we need to specify
which jumps between subtypes are allowed. Generally,
there are two reasons to limit the number of possible
jumps between states. (a) To reduce the computer
resources required by our algorithm, we need to limit the
number of possible transitions between states. (b) More
importantly, we need to make sure that a path through
our model cannot jump to the left or too far to the right.
A jump to the left would have the biological meaning of a
tandem repeat of a certain part of the sequence, which we
do not allow. A jump to the right that overjumps consen-
sus columns in one of the two subtypes involved in the
jump means that some part of one of those subtypes is
deleted with respect to the query sequence. This is possi-
ble but should be punished as in a standard profile HMM
by using the alternative path, a chain of delete states. This
exclusion of forward jumps similarly reduces the number
of transitions as done in [29]. In our approach, we
imposed the following rules:
r1 For two subtypes  i and  j, the algorithm can jump
from a match state of  i only to a match state or a delete
state of  j, and from an insert state or delete state of  i
a jump is possible only to a match state of  j.
r2 A jump from a state T in  i is possible only to the left-
most state in  j that is strictly to the right of T.
r3 A jump from a state Mi,k, Di,k or Ii,k to a state in  j that
is to the right of Mi,k+1 is not possible.
Rule r1 reduces the number of possible transitions in our
model. Rules r2 and r3 ensure that there are no insertions
or deletions introduced during a jump without using
insert or delete states.
Parameter estimation
A jpHMM has a large number of parameters that need to
be specified, namely the emission probabilities of match
and insert states, the transition probabilities within sub-
types and the probability of the jumps between different
subtypes. With the exception of the probabilities of
jumps, which is discussed below, the above probabilities
can be estimated based on observed frequencies. Given
the topology of the jpHMM, each of the sequences in the
given multiple sequence alignment defines a unique path
through the states, and gives rise to observed emissions
and transitions. For example, a particular residue that is
aligned in a consensus column is emitted from the corre-
sponding match state of the subtype the respective
sequence belongs to. To give another example, an insert
region of length l gives rise to one transition from the pre-
ceding match state to the corresponding insert state, l - 1
transitions from that insert state to itself and one transi-
tion from the insert state to the next match state.

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The generalized problem for estimating each emission
distribution and each distribution of possible transitions
out of a state is the following. We are given a count vector
 = (n1,...,ns), where s is the number of emissions (or tran-
sitions, respectively) out of this state. For example, we
have s = 4 in case of nucleotide emissions. ni is the number
of times the ith emission (or transition) is observed. These
observed frequencies   are distributed according to a
multinomial distribution with parameters   = (p1,...,ps),
where pi is the probability of observing option i. For this
problem of estimating   given  , we chose a Bayesian
approach as in [30]. This means we assume a prior distri-
bution on the set of all possible  , and then estimate 
by the following conditional expectation
E (|) .
We model this prior knowledge using a Dirichlet distribu-
tion [30] which has parameters   = (α1,...,αs). These
parameters can be interpreted as pseudocounts that are
added to the observed counts. For the emission probabil-
ities we estimated the parameters   of the prior distribu-
tion with a Maximum Likelihood approach [30] based on
the input multiple alignment. For the transition probabil-
ities we used the parameters   of the prior distribution
taken from [31]. Those were shown to perform better than
the parameters derived by Maximum Likelihood.
In contrast to the transitions within  a subtype of the
jpHMM, jumps between subtypes cannot be observed in
the input alignment data. Since we cannot estimate the
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Simplified topology of a jumping profile HMM (jpHMM) Figure 3
Simplified topology of a jumping profile HMM (jpHMM). The sequence family   is partitioned into k subtypes  1,..., k. Each 
subtype is modeled by a profile HMM here pictured as a dashed box. Arrows indicate possible transitions between states 
within the same subtypes and transitions between different subtypes, so-called jumps. For clarity we omit insert and delete 
states of the profile HMMs and sketch a case where the first three columns are consensus columns.
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A toy example of a jumping profile Hidden Markov Model Figure 4
A toy example of a jumping profile Hidden Markov Model. This is build from a multiple sequence alignment of nucleotides with 
two subtypes. The first subtype consists of three sequences with four consensus columns, the second subtype consists of two 
sequences with five consensus columns. With each match and insert state a vector is associated for the emission probability 
values corresponding to the nucleotides A, C, G and T. For clarity, some transitions are omitted. Also, the figure does not 
show the delete states immediately after B from which each match state can be reached nor the delete state immediately 
before E that can be reached from each match state. Fat lines indicate high transition probabilities, thin lines correspond to low 
probabilities.
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corresponding jump probabilities from observed frequen-
cies, we use a fixed, empirically derived value Pj for the
probability of observing a jump. If in a given state of the
jpHMM, there are several possibilities for a jump, this
probability is evenly distributed between the possible
jumps. In other words, if we have K options to jump into
another subtype, the probability of each of these jumps is
given by Pj/K. In the application of our program to the
identification of HIV and HCV recombinants we use a
jump probability of Pj = 10-9 which we derived by optimiz-
ing the results by comparing them to published HIV inter-
subtype recombination breakpoints. Taking into account
that the transition and jump probabilities out of each state
must sum up to 1, we scale the non-jump transition prob-
abilities, i.e. the probabilities for transitions within the
same subtype by multiplying them by (1 - Pj), if jumps are
possible out of this state.
Alignment algorithm and efficiency
The jumping alignment of a query sequence S = s1, s2,...,sn
and a given multiple alignment is determined by search-
ing the most probable path Q* through the jpHMM that
emits S as described above. This is done with a dynamic
programming algorithm, the Viterbi algorithm. For each
position i = 1,..., n of the query sequence S and for each
state q of the jpHMM we calculate the probability δi(q) of
the prefix s1,...,si of the query sequence and the most prob-
able path through the jpHMM ending in state q and emit-
ting s1,...,si. These probabilities are called Viterbi values
and the following recursion holds.
Here, q' ranges over all states of the model, tq' q is the prob-
ability of the transition from state q' to state q and 
is the probability of emitting nucleotide si+1 out of state q.
The Viterbi values can be computed by increasing i with
the states sorted from left to right. By backtracking we can
construct the most probable path Q* (see Figure 4) and
thus the jumping alignment. This algorithm has a com-
plexity of O(nk) in time and O(n) in space where n is
the length of the query sequence, k the number of sub-
types in the alignment and  the number of states in the
jpHMM.
In the case of very long alignments this may require too
much time and memory for current computer hardware.
For example, genomes of the HIV-1 group M have a length
of roughly 10, 000 nucleotides. Thus, given a multiple
alignment of 14 (sub-)subtypes of such sequences and a
query sequence of length ~10, 000 in a straightforward
implementation we would need to calculate and store
roughly 10, 000 · 10, 000 · 14 · 3 = 4 · 2 · 109 floating
point numbers.
To accelerate the computation and to save memory we
bound the number of considered states in each step i by
using the beam-search algorithm [32,33]. The idea behind
this algorithm is to exclude possible irrelevant paths in
each step and to restrict the search space to 'promising'
paths. If an alignment of an initial part is much worse than
another alignment of that part then we do not try to
extend that low quality alignment. This is achieved by
computing and storing in each step i a modified Viterbi
value   ≤ δi(q) only for a subset  i of the states,
namely those states q whose modified Viterbi value is not
much lower than the optimal local solution   =
maxq  These states are called 'active' states and the set
i of active states of step i is determined by
The modified Viterbi value of the inactive states is set to 0,
and does not need to be stored. In the next step i + 1 of the
recursion the modified Viterbi value   needs only
be computed for states, which can be reached from a state
in the subset of active states  i through a path with one
emission. This speeds up the computation of the recur-
sion.
In the tradeoff between memory efficiency and speed
(large  ) against accuracy (small  )) we chose a beam
in the order that allows maximal accuracy within the lim-
its of currenct PC hardware:   = 10-20. In Figure 5 and 6
we sketch the set of columns of activated states in the mul-
tiple alignment for an example with HIV sequences. Using
this beam search heuristic very rarely affects the output of
the computation but the time and memory savings are
immense. The average number of active states per input
sequence position in this example is 1,690 which com-
pares to roughly 10,000 · 14 · 3 = 4 · 2 · 105 states if the
beam search heuristic was not used. For the HIV-1
sequences that we tested, the average number of active
states was between 1,620 (CRF 12, length = 8,760 nt) and
2,862 (CRF 11, length = 9,768 nt). The CPU time for those
sequences using the beam search heuristics is 7.2 min
(CRF 12) and 13.6 min (CRF 11) on a Linux PC with 3 GB
RAM and 3.2 GHz. This includes model building as well
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as a search of one sequence against the model, but most
of the CPU time was consumed by the second step.
Test results
Results on HIV genomic sequences
To evaluate the accuracy of our jpHMM approach on HIV-
1 sequences, we used two different types of test data
including simulated as well as real-world sequence data.
First, we wanted to know to what extend our method is
able to recognize subtypes in artificial sequences pro-
duced by the underlying probabilistic model itself. This
test can be considered as a minimal check of our model.
We sampled 800 random sequences according to the tran-
sition and emission probabilities of the HMM built for
HIV-1 subtyping. Since the "jump probability" in our
model is rather small, each of our 800 artificial sequences
consisted of one subtype only without any recombina-
tions. For each of these sequences our method correctly
predicted the underlying single subtype, and no jumps
between different subtypes were predicted. Moreover, for
752 of our 800 sequences, 100 % of the individual
sequence positions were assigned to the correct subtype.
In the remaining 48 sequences, the only differences
between the sampled and predicted paths were in the
lengths of short unclassified regions at the ends of the
sequence. All in all, 99.99 % of the sequence positions in
our test sequences were assigned to the correct subtype.
Further, we used simulated  inter-subtype recombinant
sequences with known breakpoints. Artificial recom-
binant sequences were created in the following way: for
each simulated sequence, two real-world 'parent'
sequences were taken from two different clades of HIV-1.
For a fixed value X, these sequences were split at every X-
th nucleotide, and a simulated recombinant sequence was
composed of alternating segments of length X from these
two parent sequences. Thus, for two parent sequences P1
and P2 and, for example, X = 1000, the first 1000 nucleo-
tides of the artificial recombinant are from P1, nucleotides
1001 to 2000 are from P2, residues 2001 to 3000 are from
P1 etc. In the present study, we used values of X = 500,
1000, 1500. This way, known breakpoints were intro-
duced into both relatively conserved regions, and highly
variable regions, and the performance of the jpHMM
method could be assessed in both contexts. Here, we dis-
tinguish between recombinant sequences with parents
from different subtypes which we call inter-subtype recom-
binants and recombinants with parents from the same
subtype but different sub-subtypes, which we refer to as
inter sub-subtype recombinants. Sub-subtypes are clearly
distinguishable, established lineages that occur within the
subtypes, but do not have the minimal genetic distances
required to be considered an independent subtype. For
historical reasons the B and D clades are called subtypes,
but in fact the distances between these two clades corre-
spond to a sub-subtype distance [15].
Detailed section of Figure 5 Figure 6
Detailed section of Figure 5.
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Reduction of active states for a set of HIV test sequences  using the beam-search heuristics [32, 33] Figure 5
Reduction of active states for a set of HIV test sequences 
using the beam-search heuristics [32, 33]. In this example, we 
have 14 (sub-)subtypes each of which has three states per 
alignment column (match, delete and insert). Thus, a column 
corresponds to 14 × 3 = 42 states. The beam-search algo-
rithm reduces the number of active states considerably; the 
figure indicates for each position in the query sequence those 
columns that contain active states. Thus, instead of consider-
ing the entire dynamic-programming matrix, our algorithm 
needs to consider only the small strip between the two lines. 
We used a beam width of   = 10-20 and a jump probability 
of 10-9.
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The sequences used in the inter-subtype recombinants
have been created using parent sequences from the fol-
lowing subtypes (GenBank accession numbers of the par-
ent sequences are in parentheses): A1 and C (A1:
AF193275, C:AY463217); A1 and D (A1: AF193275,
D:AF133821); A1 and G (A1: AF193275, G: AF450098); B
and C (B: AF042101, C: AY463217); B and F1 (B:
AF042101, F1:AY173958); B and 01 (B: AF042101,
01:AB032741). The sequences used in the inter sub-sub-
type artificial recombinants have been created from the
following sub-subtypes and parents, respectively: A1 and
A2 (A1: AF413987, A2:AF286240); A2 and A1
(A2:AF286241, A1:AF539405); B and D (B: AF538302,
D:AJ320484); D and B (D: AJ488926, B:AY352275); F1
and F2 (F1:AY173957, F2:AF377956); F2 and F1 (F2:
AY371158, F1:AY173958). We selected the above combi-
nations of subtypes for the parent sequences, because they
correspond to known real-world recombinants. From
each subtype, we selected parent sequences for which
breakpoints are assumed to be reliably annotated. Figure
7A illustrates the creation of these artificial recombinants,
Figure 7B shows the evolutionary relations of the subtypes
and inter sub-subtypes used for our simulated recom-
binants.
Based on these artificial recombinants, we evaluated the
performance of our jpHMM tool and compared it with
Simplot [12], a widely used HIV subtyping tool. We meas-
ured the distances between the predicted and the real
breakpoints, and assessed the differences in prediction
accuracy using non-parametric statistics, namely calculat-
ing the (a) the median value of the distances and (b) the
interquartile range, and comparing distributions using the
Wilcoxon signed-rank test implemented with R http://
www.r-project.org. As shown in Figure 8, our method con-
sistently showed much better predictions of the artificial
recombinant breakpoints than Simplot. In the inter-sub-
type sequences, jpHMM's median value for the distances
between the predicted positions and the real breakpoints
is 10, with an interquartile range from 4 to 15. By contrast,
Simplot's median is 54, while its interquartile range is
from 19 to 72. The difference between the predictions of
jpHMM and Simplot is significant with p <10-9 in the Wil-
coxon signed-rank test.
The inter sub-subtype simulated sequences are more sim-
ilar to each other, and so it becomes a more difficult prob-
lem to distinguish breakpoints. Here, jpHMM's median
value for the distances between the predicted and the
actual breakpoints is 9, the interquartile range is from 3.5
to 19, while Simplot's median value is 84 and its inter-
quartile range is 19.5 to 122. The accuracy difference
between jpHMM and Simplot's predictions are significant
with p <10-7 in the Wilcoxon signed-rank test. Finally, Fig-
ure 8 also shows there were no particular breakpoints that
were consistently hard to define, rather whether or not a
particular breakpoint (for example, position 1000) was
accurately resolved depended on the particular combina-
tion of sequences; the artificial breakpoints we introduced
were embedded in both conserved and variable regions of
HIV. Introducing breakpoints at intervals of 500 and 1500
gave comparable results (data not shown) to the 1000
base intervals included in Figures 7 and 8. Finally, the
breakpoint definition methods in Simplot uses a chi
squared statistic for resolution [34].
We have tried to compare jphmm and Simplot chi square
results to the suite of programs available in the RDP pack-
age [35], including RDP, GENECONV, MaxChi, Chi-
maera, Siscan. While Simplot and jphmm readily
recognized the artificially generated breakpoints in our
recombinants, shown in Figure 7, and could distinguish
the parental subtypes, the other methods missed many of
the breakpoints and often assigned incorrect subtype des-
ignations. The LARD [36] program appears not to be
designed for recognition of multiple breakpoints. Boots-
canning works well for correct identification of the sub-
types of parental fragments in a recombinant genome,
whether using the Simplot or RDP implementation, but
does not attempt to optimally resolve breakpoints.
Another algorithm to detect recombination events has
been described in [37,38]. However, this method is lim-
ited to detect chimeric sequences that are recombinations
of only two sequences with only one breakpoint. While
the jumping alignment program JALI [8,9] can be adapted
to run on DNA sequences, its computer memory require-
ments are far too high for applying it to the test data in our
study. Thus we used the chi squared method [11,34]
implemented in Simplot [12] for Figure 8, as it gave the
best results among existing methods.
In addition to simulated recombinants, we used real-
world circulating recombinant forms (CRFs) for which the
recombination breakpoints have been very carefully
defined, and published in the literature. Here, we com-
pared only our jpHMM predictions to the published data
but not predictions by Simplot, since the published break-
points already mainly rely on predictions by Simplot or
similar methods. Thus, it would be redundant to compare
CRFs to our own revised Simplot predictions. We tested
reference sequences from 12 different CRFs, namely
CRF02 to CRF08 and CRF10 to CRF14. These recom-
binants are known to be well annotated. Figure 9 shows
the published genome map of CRF02 together with the
subtypes as predicted by our jpHMM software. For the 12
CRFs that we analyzed, subtypes predicted by jpHMM
roughly correspond to the previously published subtypes:
for 70% of the CRFs with breakpoints, the breakpoints
predicted by jpHMM are located in a distance of <150nt
from the corresponding published breakpoints (with anBMC Bioinformatics 2006, 7:265 http://www.biomedcentral.com/1471-2105/7/265
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Creation of artificial recombinants with known breakpoints to test jpHMM and Simplot accuracy Figure 7
Creation of artificial recombinants with known breakpoints to test jpHMM and Simplot accuracy. (A) The artificial recom-
binant, constructed from two different clades, has the actual breakpoints at every X-th nucleotide for X = 500, 1000, 1500. 
Only the construction with X = 1000 is shown here. (B) The phylogenetic tree demonstrates the relations and relative dis-
tances between the clades used in the artificial recombinants' construction.BMC Bioinformatics 2006, 7:265 http://www.biomedcentral.com/1471-2105/7/265
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Evaluation of breakpoints predicted by jpHMM and Simplot Figure 8
Evaluation of breakpoints predicted by jpHMM and Simplot. We measured the distance between the predicted breakpoints and 
the real breakpoints as described in the literature. For these distances, we calculated the median value and the interquartile 
range. A) Inter-subtype artificial recombinants: jpHMM's median is 10, with the interquartile range of 4–15; Simplot's median is 
54, with the interquartile range of 19–72 and p <10-9 in the Wilcoxon signed-rank test. B) Inter sub-subtype artificial recom-
binants: jpHMM's median values 9, interquartile ranges 3.5–19; Simplot's median values 84, interquartile ranges 19.5–122 and p 
<10-7 in the Wilcoxon signed-rank test. In both plots (A and B), the Y -axis represents the number of bases that predicted 
breakpoints were away from the actual ones. The median values are shown here as the white bars, and the interquartile ranges 
are shown as the black bars. Numbers in color represent the actual breakpoint positions (every 1000-th nucleotide) in all syn-
thetic recombinants. The duplicated data positions were spread apart in order to show every individual breakpoint here.BMC Bioinformatics 2006, 7:265 http://www.biomedcentral.com/1471-2105/7/265
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average distance of 27nt). Discrepancies between the pub-
lished and jpHMM predicted recombinant sequences
were found in the H, J and K-containing CRFs.
Results for the hepatitis C virus
We analyzed the two recombinant strains of HCV that
were available until mid-2005, the 1b/2k St Petersburg
recombinants (AY587845, [22]) and an artificial 1a/2a
recombinant (AF177037, [39]). In both cases, the jpHMM
method accurately reconstructed the recombinant.
jpHMM located the breakpoint for the 1b/2k St Peters-
burg recombinant between nucleotide 3186 and 3187 (in
HCV-H77 numbering). The original authors manually
pinpointed this breakpoint to the exact same nucleotide,
based on a Simplot graphic and a sequence alignment.
The location of the breakpoint of the artificial 1a/2a
recombinant was estimated to be at position 2759/2760
(HCV-H77 numbering), while the cross-over point in the
actual artificial recombinant was reported to be between
the fourth and fifth nucleotide of a mutated restriction site
Nde 1 located at position 2761–66 of their reference
sequence (the boundary of p7 and NS2). However, in the
same reference sequence (AF177037) the only site (CAT-
ATG) was located at positions 2773–2778, which corre-
sponds to 2762–2767 of HCV-H77. This would place the
breakpoint at position 2765/2766, so in this case the pre-
diction is off by 6 nucleotides.
In both recombinants, the genotype of the 5'UTR part of
the sequence was misidentified, as 1a for the 1a/2a recom-
binant and as 2a for the 1b/2k recombinant. Thus, a spu-
rious breakpoint was postulated for both sequences, at
position 238/239 for the 1b/2k recombinant and at posi-
tion 349/350 for the 1a/2a recombinant. This region of
the HCV genome, around 350 nucleotides long, is known
to be too highly conserved to contain a good phylogenetic
signal, and often cannot even be used to phylogenetically
distinguish different genotypes, let alone subtypes (CK,
unpublished results), so it is not surprising that the
jpHMM method is unable to make an accurate determina-
tion. As a consequence, for any automatic recombination
Comparison of genomic recombinations predicted by our jpHMM tool and reported in the literature Figure 9
Comparison of genomic recombinations predicted by our jpHMM tool and reported in the literature. In all reference 
sequences from CRF02 to CRF08 and CRF10 to CRF14, 70% of the jpHMM's predictions were consistent with the published 
data. As an example, the figure shows the CRF02 recombinant that consists of subtypes A (shown in red) and G (shown in 
green). Above is the prediction by jpHMM, below the recombination as reported in the literature (see [42]).BMC Bioinformatics 2006, 7:265 http://www.biomedcentral.com/1471-2105/7/265
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detection method to work accurately, we expect that this
region will have to be excluded a priori; and conversely,
because this region does contain little phylogenetic infor-
mation, detection of recombination will be almost impos-
sible.
Discussion and conclusions
We developed jpHMM, a novel probabilistic approach to
compare DNA or protein sequences to a family of aligned
sequences. In this study, we applied this tool to sequence
subtyping and classification to enhance viral sequence
quality control in the rapidly expanding HIV/HCV
sequence databases. jpHMM combines the idea of a pro-
file HMM with the jumping-alignment approach that has
been previously proposed by Spang et al. [9]. For HIV and
HCV genome sequences, we constructed profile HMMs
for each subtype of the respective virus; these models were
then connected by subtype transitions (jumps). These
jumps make it possible to detect whether a query
sequence is an inter-subtype recombinant by finding a
best reference subtype match at each position along the
entire query sequence. The results presented in this paper
demonstrate jpHMM sensitively recognizes recombinants
and gives more accurate breakpoint predictions than Sim-
plot, a widely used subtyping tool in HIV-1 sequence anal-
ysis.
As every probabilistic model, jpHMM depends on a suffi-
ciently large set of input data; our approach is therefore
limited by the subtype background sets which are used as
the model-building sequences. Our method performs best
with large input data sets to inform the model, but it may
fail to identify breakpoints if the input data set is too
small. In the present study, for example, jpHMM failed on
H, J, and K-containing CRFs. The difficulties with these
sequences could be due to the following reasons: (1)
jpHMM underestimates H, J, and K subtypes due to the
fact that they have very rarely been sampled and
sequenced, and so there are inadequate complete genome
sequences from these three subtypes to develop a good
model. (2) The current H, J, and K subtype reference
sequences probably are not good representatives for these
three subtypes, thus our jpHMM, as other subtyping tools,
can be biased predicting these particular subtypes.
Thus, in its current form, while jpHMM provides clearly
superior accuracy in terms of breakpoint definitions when
large subtype data sets were available for input, to resolve
rare subtypes it would be best to use this tool in conjunc-
tion with RIP [40] or Simplot for de novo HIV classification
of unknown sequences. In this way, recombinant frag-
ments from rare subtypes could be detected if present, and
more accurate breakpoint definitions between common
subtypes would be possible. In addition, jpHMM, like
many other subtyping tools, fails on sequence classifica-
tions in the situation where a new or unknown sequence
is discovered because there is no reference sequence avail-
able. We are currently developing another method to
solve this problem.
In the present study, we applied jpHMM to viruses; we
tested it on HIV/HCV sequences. The method, however,
has been developed as a generally applicable tool, so its
application should not be considered only in viral
genomes. It could be successfully used to DNA and pro-
tein sequences from other organisms with individual sub-
type's sequences available, and be used as one important
part in understanding the role of recombination in evolu-
tion and molecular epidemiology, and ultimately for inte-
gration into sequence quality control pipelines as a
standard step in sequence analysis.
Availability and requirements
The jpHMM program was written in C++ and the source
code is available free of charge from the authors on
request. We set up a user-friendly WWW interface for the
program at [41] which is described [42]. The circulating
recombinant forms of HIV are listed on a web page [43] of
the HIV Sequence Database.
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